Antibody Innovation Summit 202 |September 22, 2026, Paris
MImAbs is pleased to invite you to the Antibody Innovation Summit 2026, bringing together clinicians, experts from academia, CROs, biotechnology companies, and the pharmaceutical industry.
This year’s theme, « Technologies with Patient Impact: The Latest Advances in Antibody Innovation« , will explore the emerging technologies and scientific advances driving the next generation of antibody therapeutics, from discovery and engineering to clinical translation and patient benefit.
The program features Aurélien Marabelle (IGR), followed by talks from Patrick Chames (CRCM), Simon Plyte (Biomunex), Sophie Barbe (INRAE), Franck Denat (ICMUB) and other experts, ending with a panel discussion on the future of antibody innovation.
